Cite
HARVARD Citation
Mcinnes, I. et al. (n.d.). SAT0403 EFFICACY AND SAFETY OF 108 WEEKS' BIMEKIZUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: INTERIM RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY. Annals of the rheumatic diseases. pp. 1153-1154. [Online].